[PubMed] Maquart FX, et al
Inhibition of endocytosis with dynasore blocks BPC-157-induced VEGFR2 activation, demonstrating the importance of receptor trafficking in the peptide's angiogenic mechanism
AOD-9604 Research Applications & Key Findings Metabolic and Obesity Research Weight Loss and Fat Reduction Studies Initial clinical trials in obese adults showed promising results, though later studies revealed limitations
Multiply daily dose by days per week by number of weeks
Side effects: Primarily gastrointestinalnausea, vomiting, diarrhea, and constipationwhich are generally mildtomoderate and transient [4] [5]
10) Neuroprotection: Brain Injuries and Neurological Conditions: BPC-157 shows potential in protecting and repairing brain tissue, beneficial in treating neurological conditions like multiple sclerosis and Parkinson's disease (3, 4)